Source: CENTER FOR AQUACULTURE TECHNOLOGIES, INC. submitted to NRP
PARTIAL INACTIVATION OF MATERNAL GENE (PIMG) TECHNOLOGY FOR THE GENETIC CONTAINMENT OF GE FISH
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
ACTIVE
Funding Source
Reporting Frequency
Annual
Accession No.
1028965
Grant No.
2022-33522-37836
Cumulative Award Amt.
$499,996.00
Proposal No.
2022-03019
Multistate No.
(N/A)
Project Start Date
Aug 1, 2022
Project End Date
Jul 31, 2025
Grant Year
2022
Program Code
[HX]- Biotechnology Risk Assessment
Recipient Organization
CENTER FOR AQUACULTURE TECHNOLOGIES, INC.
8395 CAMINO SANTA FE STE E
SAN DIEGO,CA 92121
Performing Department
(N/A)
Non Technical Summary
There is a need to develop effective sterilization strategies to ensure safe deployment of genetically engineered (GE) fish with improved genetics. Sterile fish have been produced by triploidization and a variety of other genetic or non-genetic methodologies. However, these approacheshave not been widely adopted by the industry due to their high cost or negative effect on fish health or performance.Our goals here is to limit the spread of GE genes into wild populations by engineering commercially farmed fish to be sterile. We identified three genes whose RNA products are deposited in the eggs by the mother to instruct Primordial Germ Cells formation in her progeny (PGCs, the cell lineages that produce sperm and eggs). We found that their full inactivation causes somatic lethality or pure sterility preventing mutant females to produce sterile progeny. To overcome this problem, we will investigate the function of evolutionary conserved regulatory 3'UTR motifs predicted to restrict expression of those genes to PGCs. We believe that disruption of such motifs will result in transient interruption of the gene function during embryonic development. This "Partial Inactivation of Maternal Gene", or so called PIMG, only blocks PGC formation without affecting other essential gene activities at later developmental stages.PIMG represents a novel approach to sterilization and a potential solution to the biological containment of GE fish. Our ultimate objective will be to use prescise genome editing toolsto generate newlines of tilapia in which the maternal PGC instruction mechanism is disrupted causing PIMG females to consistently produce 100% sterile progeny. If successful, this project will enable safe and effective utilization of GE fish in a wide range of commercial applications.
Animal Health Component
45%
Research Effort Categories
Basic
45%
Applied
45%
Developmental
10%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
3013714105030%
3033719108030%
3040810102030%
3050810108110%
Goals / Objectives
The major goalof thisproject is to engineer commercial farmfish to be sterile.Objective 1. Identify 3'UTR motifs essential for maternal delivery of mRNA into the germ plasm/PGCs.In this objective we will use reporter mRNA injection experiments to identify 3'UTR motifs necessary to mediate PGC specific expression. Working in iterative cycles, we will design, synthesize, and test the effect of disrupting either one or a combination of conserved 3'UTR cis-acting-regulatory motifs, to identify those required and sufficient to mediate PGC specific expression. These efforts will yield information on 3'UTR regulatory networks controlled by miRs and RNA Binding Proteins that modulate mRNA stability and will deliver insights into the mechanisms that are functionally important during PGC development.Objective 2. Generation of F0 founder carrying 'de novo' alleles for 3 germ line genes.In objective 2, we will perform homology-directed repair (HDR) facilitated by phenotypic selectionto cut out the WT (wild-type)-3'UTR sequences and paste the new 3'UTR alleles with altered cis-regulatory elements selected as part of objective1. Three DNA variant with 3'UTR mutations flanked by CRISPR target sites will be generated synthetically and cloned into a donor plasmid. One-cell stage tilapia embryos will be injected with a solution containing Cas9mRNA, sgRNAs with the donor plasmid DNA. To test for efficient HDR, fin DNA samples from selected fish at 2-3 months of age will be extracted and analyzed by junction fragment PCR. Based on previous work at CAT, we expect that injection of 600 embryos will produce new mutant lines with defective PGC development pathway. Batches of these F0 treated embryos will be raised for further analysis. We expect mosaic mutant females to produce embryos, some of which with reduced PGC counts.Objective 3. Establish Tilapia lines, characterize their phenotypes, and demonstrate maternal effect PGC ablation. In objective 3 we will first outcross F0 mutated males with WT females carrying the GFP transgene driving a PGC expression patternto establish lines. F1 progeny will then be screened to locate individuals carrying the precise allelic replacement event. Finally, F1 progeny carrying the same 3'UTR mutation will be incrossed to produce F2 progeny. This F2 progeny will be raised to adulthood, sexed, and genotyped to identify homozygous mutant. Homozygous mutant females carrying the GFP transgene should produce PGC depleted progeny that will grow into sterile or sub-fertile adult. Sterility will be studied at the morphological cellular and molecular level in 3 and 5-month-old F3 progenies. In contrast to females, homozygous mutant males should produce progeny with a normal PGC count.
Project Methods
We will first synthetize a total of nine allelic variant 3'UTRs and fuse them to a red fluorescent protein (RFP) reporter gene, then express the corresponding RNAs and monitor their PGC specific expression in injected embryos under fluorescent microscopy. Each embryo will be co-injected with an equal amount of the corresponding intact-3'UTR sequence fused to GFP. Images of 10 embryos per treatment will be taken using standardized settings and fluorescence intensity will be measured. We expect that when normalized for GFP expression, RFP expression will either be significantly reduced or undetectable. If the RFP signal is not fully lost, additional 3'UTR variant will be produced and tested. Mean total PGCs will be statistically compared using an unpaired t-test. Significance will be accepted when P < 0.05.For each allelic replacement experiment we will design and test several guide RNAs (sgRNA) to identify the most efficient at creating indel mutations (>70%), one positioned upstream and one downstream the DNA region to be replaced. We will then create three constructs in which the DNA fragments containing the desired modifications are flanked by two tyrosinase CrispR/Cas9 target sites to liberate the homology arms and drive integration of donor DNA. Treated embryoswith defective melanin pigmentation will be raised for further analysis. At 2-3 months of age their fin DNA samples will be extracted and both 5′ and 3′ allele replacement junctions will beamplified by PCR using one primer specific to the modified 3'UTR and one outside the modified DNA region. Fish producing desired amplicons will be raise to adulthood to test for germline transmission.Given the gene dosage sensitivity seen in null alleles of those genes, we expect mosaic mutant females to produce embryos, some of which with reduced PGC counts. Likewise, if the mutations are indeed maternal-effect specific, we expect F0 males to produce F1 progeny with a normal PGC counts (~35+/- 5 PGCs/embryo). The mean total PGC numbers will be statistically compared across F1 progenies using an unpaired t-test.Homozygous mutant females carrying desired 3'UTR modificationshould produce germ cell depleted progeny that will grow into sterile or sub-fertile adult. Sterility in males will be evidenced by translucid testes and in females by string-like ovary. Sterility will be confirmed in QPCR experiments by the absence of vasa (a germ cell specific gene) expression in the gonads. For further confirmation,dissected gonads will be fixed (n=10/group) in Bouin's solution, dehydrated and infiltrated with paraffin for sectioning. Sterility will be apparent from a complete absence of germ cells studied at the morphological cellular and molecular level in 3 and 5-month-old F3 progenies. In contrast to females, homozygous mutant males should produce progeny with a normal PGC count. Finally, Utilizing the mutant line exhibiting the most complete PGC ablation effect, performance in culture will be assessed through grow-out trials. Each fish will be individually weighed and measured at 4-week intervals over a 24-week period. At the end of the experiment, fish will be sacrificed, sexed, the mean total fish length, weight, filet yield and growth curves will be statistically compared. Parametric data will besubjected toone-way ANOVA. Whenthe factorwill be detected to be significant(P<0.05), the means among the treatments will be compared usingTukey's multiple comparisontest.

Progress 08/01/23 to 07/31/24

Outputs
Target Audience:Our target audience includes members of the scientific community focused on fish reproduction and physiology, aquaculturists, government risk assessors and policymakers, as well as biotechnology companies interested in genetic engineering technologies. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?The project has provided training and growth opportunities for Mr. T. Umazume, who is currently pursuing a PhD, Mr. S. Samu, who holds an MS degree, and Mr. B. Tsai, a Bachelor of Science (BS) graduate. Each of them has made significant contributions to molecular and gene editing research, including the development of custom nucleases, embryo microinjection, and genotype and phenotype analysis. Additionally, two individuals received fish husbandry training through the project--one in a full-time position with a BS degree, and the other as a part-time undergraduate student. How have the results been disseminated to communities of interest? Presentation to the 9th International Workshop on the Biology of Fish Gametes in Leon, Spain. 9th International Workshop on the Biology of Fish Gametes 15th - 18th July 2024 León (Spain) with the Oral Communication "Partial inactivation of maternal effect gene to induce fish sterility" Sea grant aquaculture academic learning sessionVirtual Session #2, Monday, July 1, 2024: How and where genetic tools can be applied for responsible aquaculture production" Virtual presentation: Tuesday, May 21st,2024 Annual Project Director's Meeting: "Partial Inactivation Of Maternal Gene (PIMG) Technology For The Genetic Containment Of GE Fish" Presentation to the NRSP-8 Aquaculture group meeting in Raleigh, NC, 2023 "Precision Breeding to Control Gender and Fertility in Finfish, Optimize Production and Minimize aquaculture footprint" What do you plan to do during the next reporting period to accomplish the goals?In the next reporting period, we will outcross F1 nos3 3'UTR variantswith nos3mutants (nos3Δ5/+) to produce compound heterozygous (nos3Δ5/3'UTR-AR2,3,4). We will further incross nos3 3'UTR variants. To assay the maternal effect function of the 3'UTR mutations we will breed compound heterozygotes (dnd1Δ16/3'UTR-AR3, AR5, nos3Δ5/3'UTR-AR2,3,4) and F2 homozygous females (e.g.,nos33'UTR-AR2,3,4/3'UTR-AR2,3,4)with wild-type males, thenanalyze the PGCs in developing embryos. We expect that mutations in the cis-regulatory motifs will destabilize maternal RNA, leading toPGC ablation. This progeny will be raised to 3 months of age, at which point we will analyze the gonads at the morphological, cellular, and molecular levels to determine the extentof germline ablation.

Impacts
What was accomplished under these goals? Objective 2: To increase the range of nos3 3'UTR regulatory motif disruption, we performed additional embryo microinjections using two new donor plasmids, pNos-AR2 and pNos-AR4, containing nucleotide modifications in two and four cis-acting stabilizing elements respectively. To assess integration of these variant 3'UTR sequences in F0 fish treated with any of five donor vectors (pNos-AR2, pNos-AR3, pNos-AR4, pDnd-AR3, pDND-AR5), we extracted genomic DNA from fins of fish with melanin pigmentation defects (around 10%) and conducted PCR of the target region and sequencing using Oxford Nanopore technology. Reads from 100 fish were aligned to the tilapia genome and analyzed with Crispresso software. We generated F0 tilapia mutants for the nos3 3'UTR, incorporating two, three, or four motif substitutions, and for the dnd1 3'UTR, with three or five motif substitutions, successfully confirming the integration of all donor sequences. In total, we established 20 founder lines, achieving an average germline 3'UTR replacement efficiency of 3%. Further analysis of mutation frequency in sperm and fin DNA from founder males revealed a positive correlation between mutation rates in somatic and germ cells, suggesting that the mutations were equally viable in both cell types. We found three F0 males (two dnd1 and one nos3 3'UTR variants) with a germline knock-in rates exceeding 90%, indicating that these mutations did not impair spermatogonia viability. Objective 3: We outcrossed the F0 dnd1 3'UTR founders with a tilapia line heterozygous for the loss-of-function dnd1 allele (dnd1Δ16/+). From this cross, we selected 163 F1 heterozygous fish (dnd13'UTR-AR3/+, dnd13'UTR-AR5/+) and 204 compound heterozygotes (dnd1Δ16/3'UTR-AR3, dnd1Δ16/3'UTR-AR5) representing the full spectrum of combinatorial mutations. F0 nos3 3'UTR founders were also outcrossed with wild-type (WT) lines, and the resulting heterozygous progeny (N=70) are being reared. These F1 fish were further divided into two groups of six mutants each for nos3 3'UTR and dnd1 3'UTR, considering the presence or absence of small deletions (scars) at the CrispR-Cas9 cut sites. Since dnd1 compound heterozygotes possess one loss-of-function allele and one intact coding sequence linked to a 3'UTR with altered cis-regulatory elements, the zygotic function of these mutated elements was assessed in the F1 generation. F1 females with up to five mutated cis-regulatory elements were dissected at 3-4 months (dnd1Δ16/3'UTR-AR3, dnd1Δ16/3'UTR-AR5), showing normal ovarian development. Males with dnd1Δ16/3'UTR-AR5 alleles produced functional sperm. These results suggest that the most extensive dnd1 3'UTR motifs alteration causes no harmful zygotic effects. In contrast, F1 compound heterozygous with a deleted 3'UTR region (dnd1Δ16/3'UTR-Δ170) were sterile, mimicking the dnd1 null mutant phenotype (dnd1Δ16/Δ16).

Publications


    Progress 08/01/22 to 07/31/23

    Outputs
    Target Audience: Nothing Reported Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?The project has provided training and growth prospects for Mr. T. Umazume, holding a Master of Science (MS), Ms. Y. Takahashi with an MS degree, and Mr. S. Samu, also with an MS, along with Mr.T. Gilmore, who holds a Bachelor of Science (BS). Each of these individuals has made substantial contributions to the molecular and gene editing research, including the creation of customized nucleases, embryo microinjection, and the analysis of both genotypes and phenotypes. Additionally, two individuals received fish husbandry training under the project - one occupying a full-time position with a BS degree, while the other served as a part-time undergraduate student. How have the results been disseminated to communities of interest? Nothing Reported What do you plan to do during the next reporting period to accomplish the goals?To expand the pool of candidates with allelic replacement, we plan to conduct additional microinjections. Subsequently, we will rear the chosen fish to sexual maturity and cross the F0 males with wild-type (WT) females. The F1 offspring resulting from this cross will undergo PCR screening to identify individuals harboring the precise allelic replacement event. Upon identification, the male germ line mutants will be crossed with mutant lines carrying heterozygous null mutations in either nanos or dnd1 genes. This will enable the creation of individuals possessing only one functional copy of these genes, while being genetically linked to their modified 3'UTR.

    Impacts
    What was accomplished under these goals? Objective 1: For further investigation of germ cell specific gene3'UTR regulatory mechanism, we selected fiveRNA stabilizing motifs in the dnd1 3'UTR and threein the nanos 3'UTR sequences. To ensure effective allelic replacement, we initially examined up to three pairs of gRNAs flankingthe 3'UTR genomic DNA regions of interest, comparing their editing efficiency and embryonic toxicity upon co-injectionwith Cas9 mRNA into fertilized eggs. Specifically, Cas9-treated embryos were injected with a gRNA targeting the tyrosinase gene, along with a set of upstream and downstream 3'UTR specific gRNAs. Across fivetreatment groups, survival rates varied, ranging from 1% to 19%. We then analyzed the frequency of indels at the upstream and downstream 3'UTR locations in theembryos displaying pigmentation abnormalities, resulting from successfull editingat thetyrosinase loci. Following a meticulous evaluation, we identified pairs that exhibited the highest editing efficiency with the least toxicity. We ultimately selected two combinations of gRNAs for removing the WT-dnd1 3'UTR sequence and one combination for excising the WT-nanos 3'UTR sequence. Objective 2: Building on the findings of objective 1, we opted to generate a total of four donor plasmids. The design of the nanos 3'UTR donor vector included nucleotide sequence modifications in three cis-acting stabilizing elements (pNos-AR3). For the dnd1 3'UTR donor vector, we integrated synthetic DNA with alterations in either three or five cis-acting stabilizing motifs (pDnd-AR3 and pDnd-AR5). To execute each allelic replacement experiment, we initially conducted a preliminary toxicity study assessing each design at three different donor DNA concentrations. One-cell stage tilapia embryos received an injection of a solution containing Cas9 mRNA, three sgRNAs, and the donor plasmid DNA at final concentrations of 12.5ng/ul, 20ng/ul, or 40ng/ul. Toxicity levels increased with rising DNA concentration, leading to survival rates ranging from 17% to 0.3%. For subsequent injections, we decided to use a final concentration of the donor vector set at 13ng, resulting in an average embryo survival rate of 10%. Approximately 10-30% of surviving embryos following injection exhibited a loss of the melanic pigment phenotype, indicating gene editing activity, with potential plasmid linearization and integration at the targeted loci. So far, from around 6000 embryos collectively injected using three donor vectors, we identified approximately 90 F0 candidate allelic replacement (AR) individuals exhibiting a mosaic pigment phenotype (N=29 for pDnd-AR5, N=58 for pNos-AR3, N=5 for pDnd-ARup). These candidates will undergo screening at sexual maturity to identify those displaying germ-line replacement of the 3'UTR sequences.

    Publications